CyberKnife’s precise delivery allows the expansion of stereotactic radiosurgery and stereotactic body radiation therapy treatments to indications not possible to treat on any other radiation therapy machine.
Read about two large prospective, multi-institutional and CyberKnife® System only clinical studies report excellent clinical outcomes at
five years post-treatment.
Summary of a prospective clinical study that shows Cyberknife performs effectively & comparability to Gamma Knife for treating Trigeminal Neuralgia, but with better patient comfort.
The purpose of this study is to assess the short and long-term outcomes after CyberKnife stereotactic radiosurgery for early stage non-small cell lung cancer (NSCLC)
This study is an international multicenter randomized study of organ confined low and intermediate risk prostate cancer and is composed of two parallel randomization schemes
Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.
Learn how Accuray radiation technologies enable clinicians to get patients back to living their lives, faster. Explore coming innovations that unlock entirely new possibilities.
The following pages explore some of the many ways clinicians around the globe use Accuray technologies to deliver unique and effective treatments for a wide range of clinical indications.
Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.
